Cite
HARVARD Citation
Zmetakova, I. et al. (2019). A disintegrin and metalloprotease 23 hypermethylation predicts decreased disease‐free survival in low‐risk breast cancer patients. Cancer science. 110 (5), pp. 1695-1704. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Zmetakova, I. et al. (2019). A disintegrin and metalloprotease 23 hypermethylation predicts decreased disease‐free survival in low‐risk breast cancer patients. Cancer science. 110 (5), pp. 1695-1704. [Online].